SCHEMBL4846358

SCHEMBL4846358

O=C1c2ccccc2-c2nn(CC3CO3)c3cccc1c23

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EIF2AK2 P19525 2/20 0.53
▸ MAPK12 P53778 2/20 0.53
▸ MAPK13 O15264 1/20 0.53
▸ MAPK11 Q15759 1/20 0.53
▸ MAPK14 Q16539 1/20 0.53
▸ DHFR P00374 1/20 0.43
▸ TOP2A P11388 10/20 0.38
▸ HTT P42858 3/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ PARP1 P09874 1/20 0.37
▸ PARP2 Q9UGN5 1/20 0.37
▸ PARP3 Q9Y6F1 1/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ LMNA P02545 2/20 0.37
▸ MAPT P10636 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8176664 0.78 EIF2AK2 (0.66) EIF2AK2MAPK12MAPK13MAPK11MAPK14
SCHEMBL14196859 0.77 LRRK2 (0.34) EIF2AK2MAPK12MAPK13MAPK11MAPK14
SCHEMBL11120339 0.76 EIF2AK2 (0.62) EIF2AK2MAPK12MAPK13MAPK11MAPK14
SCHEMBL30821077 0.70 EIF2AK2 (0.67) EIF2AK2MAPK12MAPK13MAPK11MAPK14
SCHEMBL8171875 0.70 EIF2AK2 (1.00) EIF2AK2MAPK12MAPK13MAPK11MAPK14
SCHEMBL8172006 0.70 EIF2AK2 (0.54) EIF2AK2MAPK12MAPK13MAPK11MAPK14
SCHEMBL10349467 0.66 EIF2AK2 (0.56) EIF2AK2MAPK12MAPK13MAPK11MAPK14
SCHEMBL13147782 0.64 EIF2AK2 (0.50) EIF2AK2MAPK12MAPK13MAPK11MAPK14
SCHEMBL9286184 0.64 EIF2AK2 (0.53) EIF2AK2MAPK12MAPK13MAPK11MAPK14
SCHEMBL10920505 0.64 DHFR (0.66) DHFRHTTL3MBTL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7364825-B2 Charge transport materials having a nitrogen-containing-heterocycle hydrazone group SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-04-29 — — US disclosed
US-20060177750-A1 Charge transport materials having a nitrogen-containing-heterocycle hydrazone group S-PRINTING SOLUTION CO., LTD. (KR) 2006-08-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060177750-A1 Charge transport materials having a nitrogen-containing-heterocycle hydrazone group SLC1A2, SLC9B2, SLC6A19 EIF2AK2 4482/4885MAPK12 2969/4885MAPK13 2936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback